Drug Shortage Report for PIPERACILLIN AND TAZOBACTAM FOR INJECTION

Last updated on 2025-02-19 History
Report ID 235624
Drug Identification Number 02402076
Brand name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Common or Proper name PIPERACILLIN AND TAZOBACTAM FOR INJECTION
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) TAZOBACTAM PIPERACILLIN
Strength(s) 0.375G 3G
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes Vial
ATC code J01CR
ATC description BETA-LACTAM ANTIBACTERIALS, PENICILLINS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2024-08-21
Estimated end date Unknown
Actual end date 2025-02-18
Shortage status Resolved
Updated date 2025-02-19
Company comments Please be informed PIPERACILLIN AND TAZOBACTAM FOR INJECTION is now available under Eugia label DIN: 02528703
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Anahita Rostami

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v14 2025-02-19 French Compare
v13 2025-02-19 English Compare
v12 2024-10-28 French Compare
v11 2024-10-28 English Compare
v10 2024-10-28 English Compare
v9 2024-09-19 French Compare
v8 2024-09-19 English Compare
v7 2024-08-29 French Compare
v6 2024-08-29 English Compare
v5 2024-08-23 French Compare
v4 2024-08-23 English Compare
v3 2024-08-22 English Compare
v2 2024-08-21 French Compare
v1 2024-08-21 English Compare

Showing 1 to 14 of 14